Soleus Capital Management, L.P. Theratechnologies Inc. Transaction History

Soleus Capital Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.01 $183,300 - $237,350	235,000 Added 2.59%	9,325,511 $7.83 Million
Q1 2023 May 15, 2023	BUY	$0.72 - $1.12 $209,797 - $326,352	291,386 Added 3.31%	9,090,511 $7.36 Million
Q4 2022 Feb 14, 2023	BUY	$0.83 - $2.3 $656,871 - $1.82 Million	791,411 Added 9.88%	8,799,125 $7.74 Million
Q3 2022 Nov 14, 2022	BUY	$1.98 - $2.42 $366,897 - $448,430	185,302 Added 2.37%	8,007,714 $19 Million
Q2 2022 Aug 15, 2022	BUY	$2.21 - $2.7 $288,029 - $351,891	130,330 Added 1.69%	7,822,412 $17.8 Million

Q4 2021 Feb 14, 2022	BUY	$2.92 - $3.76 $232,721 - $299,668	79,699 Added 1.05%	7,692,082 $23.3 Million
Q3 2021 Nov 15, 2021	BUY	$3.28 - $4.07 $1.92 Million - $2.38 Million	584,287 Added 8.31%	7,612,383 $28.5 Million
Q2 2021 Aug 16, 2021	BUY	$3.43 - $3.96 $263,249 - $303,926	76,749 Added 1.1%	7,028,096 $27.3 Million
Q1 2021 May 17, 2021	BUY	$2.2 - $3.94 $15.3 Million - $27.4 Million	6,951,347 New	6,951,347 $26.9 Million

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $133M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.